X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (28408) 28408
Magazine Article (78) 78
Newspaper Article (64) 64
Newsletter (60) 60
Book / eBook (45) 45
Book Chapter (45) 45
Dissertation (15) 15
Web Resource (12) 12
Conference Proceeding (8) 8
Publication (5) 5
Book Review (4) 4
Reference (3) 3
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26467) 26467
male (16415) 16415
female (14757) 14757
middle aged (14222) 14222
aged (12827) 12827
esophageal cancer (9467) 9467
esophageal neoplasms - pathology (9450) 9450
cancer (8182) 8182
oncology (7991) 7991
adult (7802) 7802
surgery (7579) 7579
esophageal neoplasms - surgery (7077) 7077
esophageal neoplasms - therapy (5874) 5874
prognosis (5099) 5099
esophageal neoplasms - drug therapy (4828) 4828
gastroenterology & hepatology (4523) 4523
aged, 80 and over (4482) 4482
treatment outcome (4446) 4446
esophageal neoplasms - mortality (4202) 4202
retrospective studies (3883) 3883
chemotherapy (3861) 3861
neoplasm staging (3791) 3791
esophageal neoplasms - radiotherapy (3709) 3709
carcinoma, squamous cell - pathology (3568) 3568
adenocarcinoma (3485) 3485
esophagus (3460) 3460
carcinoma (3401) 3401
combined modality therapy (3337) 3337
esophagectomy (2890) 2890
care and treatment (2864) 2864
radiotherapy (2773) 2773
adenocarcinoma - pathology (2743) 2743
medicine & public health (2683) 2683
survival rate (2679) 2679
squamous cell carcinoma (2641) 2641
squamous-cell carcinoma (2637) 2637
antineoplastic combined chemotherapy protocols - therapeutic use (2619) 2619
follow-up studies (2608) 2608
survival (2593) 2593
analysis (2452) 2452
carcinoma, squamous cell - surgery (2387) 2387
esophageal neoplasms - diagnosis (2297) 2297
esophageal neoplasms - genetics (2213) 2213
risk factors (2202) 2202
chemoradiotherapy (2201) 2201
tumors (2178) 2178
esophageal neoplasms - metabolism (2140) 2140
carcinoma, squamous cell - therapy (2139) 2139
metastasis (2127) 2127
research (2087) 2087
esophageal squamous cell carcinoma (2077) 2077
therapy (2051) 2051
carcinoma, squamous cell - mortality (1961) 1961
adenocarcinoma - surgery (1947) 1947
carcinoma, squamous cell - drug therapy (1875) 1875
health aspects (1864) 1864
esophageal neoplasms - complications (1846) 1846
survival analysis (1807) 1807
lymphatic metastasis (1800) 1800
expression (1678) 1678
cell line, tumor (1668) 1668
neoadjuvant therapy (1624) 1624
animals (1621) 1621
adenocarcinoma - therapy (1579) 1579
cisplatin - administration & dosage (1561) 1561
prospective studies (1541) 1541
immunohistochemistry (1527) 1527
esophagoscopy (1504) 1504
diagnosis (1502) 1502
esophageal neoplasms - diagnostic imaging (1487) 1487
carcinoma, squamous cell - radiotherapy (1475) 1475
mortality (1469) 1469
fluorouracil - administration & dosage (1468) 1468
esophagectomy - methods (1467) 1467
palliative care (1425) 1425
time factors (1415) 1415
abridged index medicus (1408) 1408
endoscopy (1398) 1398
patients (1394) 1394
radiology, nuclear medicine & medical imaging (1358) 1358
esophageal neoplasms (1321) 1321
radiotherapy dosage (1321) 1321
adenocarcinoma - mortality (1300) 1300
cancer therapies (1274) 1274
medical prognosis (1272) 1272
gastroenterology (1226) 1226
stomach neoplasms - pathology (1225) 1225
barrett esophagus - pathology (1217) 1217
apoptosis (1216) 1216
adenocarcinoma - drug therapy (1199) 1199
carcinoma, squamous cell - genetics (1176) 1176
carcinoma, squamous cell - metabolism (1168) 1168
disease-free survival (1159) 1159
esophagus - pathology (1116) 1116
chemotherapy, adjuvant (1087) 1087
antineoplastic agents - therapeutic use (1074) 1074
cisplatin (1070) 1070
development and progression (1065) 1065
barretts-esophagus (1043) 1043
tomography, x-ray computed (1034) 1034
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (17) 17
Online Resources - Online (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Credit Valley Hospital - Stacks (2) 2
Scarborough Hospital - Online (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Toronto East General Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (25816) 25816
Japanese (1429) 1429
German (738) 738
French (479) 479
Russian (445) 445
Chinese (400) 400
Spanish (173) 173
Italian (164) 164
Polish (61) 61
Portuguese (53) 53
Dutch (42) 42
Hungarian (41) 41
Korean (38) 38
Czech (25) 25
Danish (18) 18
Romanian (14) 14
Croatian (11) 11
Hebrew (11) 11
Serbian (9) 9
Norwegian (8) 8
Bulgarian (7) 7
Finnish (6) 6
Swedish (6) 6
Ukrainian (5) 5
Slovak (3) 3
Afrikaans (2) 2
Greek (2) 2
Icelandic (2) 2
Lithuanian (2) 2
Persian (2) 2
Arabic (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2012, Volume 83, Issue 3, pp. 878 - 886
Purpose To analyze the long-term survival and tumor control outcomes after stereotactic body radiotherapy (SBRT... 
Radiology | Hematology, Oncology and Palliative Medicine | Stereotactic body radiotherapy | Breast cancer | Oligometastases | Survival | Metastases | ACR PRACTICE GUIDELINES | PHASE I/II TRIAL | HEPATIC RESECTION | CELL LUNG-CANCER | LIVER METASTASES | ONCOLOGY ASTRO | ONCOLOGY | COLORECTAL-CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | AMERICAN SOCIETY | RADIATION-THERAPY SBRT | TUMOR VOLUME | Bone Neoplasms - mortality | Sarcoma - secondary | Prospective Studies | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Carcinoma, Squamous Cell - surgery | Liver Neoplasms - mortality | Radiosurgery - adverse effects | Brain Neoplasms - surgery | Esophageal Neoplasms - pathology | Brain Neoplasms - secondary | Carcinoma, Squamous Cell - mortality | Lung Neoplasms - secondary | Sarcoma - mortality | Aged, 80 and over | Adult | Female | Brain Neoplasms - mortality | Liver Neoplasms - secondary | Radiosurgery - methods | Colorectal Neoplasms - mortality | Neoplasm Metastasis - radiotherapy | Liver Neoplasms - surgery | Lymphatic Metastasis | Bone Neoplasms - surgery | Adenocarcinoma - secondary | Head and Neck Neoplasms - pathology | Breast Neoplasms - pathology | Sarcoma - surgery | Breast Neoplasms - mortality | Carcinoma, Squamous Cell - secondary | Lung Neoplasms - surgery | Aged | Head and Neck Neoplasms - mortality | Colorectal Neoplasms - pathology | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Radiotherapy | Nuclear radiation | Analysis | Radiation | MULTIVARIATE ANALYSIS | PATIENTS | MAMMARY GLANDS | NEOPLASMS | METASTASES | RADIOLOGY AND NUCLEAR MEDICINE | DEATH | REGRESSION ANALYSIS | RADIOTHERAPY | HAZARDS | SKELETON
Journal Article
CA: a cancer journal for clinicians, ISSN 0007-9235, 2016, Volume 66, Issue 5, pp. 408 - 436
Answer questions and earn CME/CNE In this report, a team of surgical pathologists has provided a review of intraepithelial neoplasia in a host of (but not all)... 
carcinoma in situ | dysplasia | intraepithelial neoplasia | preinvasive neoplasia | precancer | HIGH-GRADE DYSPLASIA | URINARY-BLADDER | BARRETTS-ESOPHAGUS | HUMAN-PAPILLOMAVIRUS | INTRADUCTAL CARCINOMA | CARCINOMA IN-SITU | PAPILLARY UROTHELIAL HYPERPLASIA | ONCOLOGY | SINGLE ACADEMIC CENTER | TERM-FOLLOW-UP | NECK-CANCER IMPLICATIONS | Humans | Lung Neoplasms - metabolism | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Male | Uterine Cervical Neoplasms - pathology | Head and Neck Neoplasms - metabolism | Breast Neoplasms - metabolism | Esophageal Neoplasms - pathology | Breast Neoplasms - therapy | American Cancer Society | Uterine Cervical Neoplasms - metabolism | Skin Neoplasms - diagnosis | Urinary Bladder Neoplasms - pathology | Female | Ovarian Neoplasms - metabolism | Uterine Cervical Neoplasms - therapy | Skin Neoplasms - pathology | Prostatic Neoplasms - pathology | Uterine Cervical Neoplasms - diagnosis | Skin Neoplasms - therapy | Carcinoma in Situ - pathology | Ovarian Neoplasms - diagnosis | Pancreatic Neoplasms - pathology | Risk Factors | Head and Neck Neoplasms - therapy | Lung Neoplasms - therapy | Carcinoma in Situ - therapy | Head and Neck Neoplasms - pathology | Skin Neoplasms - metabolism | Breast Neoplasms - pathology | Ovarian Neoplasms - therapy | Head and Neck Neoplasms - diagnosis | Breast Neoplasms - diagnosis | Carcinoma in Situ - diagnosis | Carcinoma in Situ - metabolism | Lung Neoplasms - diagnosis | Population Surveillance | Prevention | Care and treatment | Gastrointestinal system | Practice | Pathologists | Metastasis | Patients | Health aspects | Cervical cancer | Risk factors | Pathology | Usage | Diagnosis | Tumors | Medical diagnosis | Cancer
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 1, pp. 127 - 135
... (O/E = 0.78; CI, 0.72–0.84), and esophagus (O/E = 0.58; CI, 0.37–0.86) SPMs. Patients receiving external-beam radiotherapy for endometrial... 
Radiology | Hematology, Oncology and Palliative Medicine | Radiation-induced malignancies | HNPCC | Endometrial cancer | Second primary malignancies | SURGERY | LYNCH-SYNDROME | NONPOLYPOSIS COLORECTAL-CANCER | 2ND PRIMARY CANCERS | RISK | CERVICAL-CANCER | RADIATION-THERAPY | UTERINE | ONCOLOGY | OVARIAN | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | United States - epidemiology | Colonic Neoplasms - genetics | Follow-Up Studies | Humans | Middle Aged | Bone Neoplasms - epidemiology | Pharyngeal Neoplasms - etiology | Esophageal Neoplasms - epidemiology | Incidence | Vaginal Neoplasms - genetics | Young Adult | Neoplasms, Radiation-Induced - genetics | Endometrial Neoplasms - genetics | Lung Neoplasms - etiology | Aged, 80 and over | Intestine, Small - radiation effects | Bone Neoplasms - genetics | Neoplasms, Second Primary - genetics | Mouth Neoplasms - genetics | SEER Program | Risk Assessment | Vaginal Neoplasms - etiology | Mouth Neoplasms - etiology | Neoplasms, Second Primary - epidemiology | Mouth Neoplasms - epidemiology | Pharyngeal Neoplasms - genetics | Vaginal Neoplasms - epidemiology | Adolescent | Pharyngeal Neoplasms - epidemiology | Endometrial Neoplasms - radiotherapy | Esophageal Neoplasms - etiology | Age Factors | Neoplasms, Radiation-Induced - etiology | Urinary Bladder Neoplasms - genetics | Adult | Female | Intestinal Neoplasms - genetics | Urinary Bladder Neoplasms - epidemiology | Colonic Neoplasms - etiology | Lung Neoplasms - genetics | Urinary Bladder Neoplasms - etiology | Colonic Neoplasms - epidemiology | Intestinal Neoplasms - etiology | Intestinal Neoplasms - epidemiology | Bone Neoplasms - etiology | Neoplasms, Second Primary - etiology | Lung Neoplasms - epidemiology | Esophageal Neoplasms - genetics | Aged | Neoplasms, Radiation-Induced - epidemiology | Genetic aspects | Research | Oncology, Experimental | Cancer | Index Medicus | LARGE INTESTINE | GASTROINTESTINAL TRACT | ORAL CAVITY | ESOPHAGUS | DIGESTIVE SYSTEM | LUNGS | MEDICINE | PHARYNX | THERAPY | RADIOLOGY AND NUCLEAR MEDICINE | BLADDER | RADIOTHERAPY | RADIOLOGY | SMALL INTESTINE | NEOPLASMS | UTERUS | INTESTINES | NUCLEAR MEDICINE | FEMALE GENITALS | ORGANS | URINARY TRACT | DISEASES | RESPIRATORY SYSTEM | BRACHYTHERAPY | BODY
Journal Article
British Journal of Cancer, ISSN 0007-0920, 01/2010, Volume 102, Issue 1, pp. 220 - 226
BACKGROUND: Radiotherapy for breast cancer reduces disease recurrence and breast cancer mortality... 
Risk | Breast cancer | Radiotherapy | Second primary neoplasms | Radiation | MORTALITY | QUALITY | LUNG-CARCINOMA | breast cancer | second primary neoplasms | RADIATION-THERAPY | WOMEN | IRRADIATION | CONTRALATERAL BREAST | ONCOLOGY | radiation | INCREASED RISK | radiotherapy | EXPOSURES | risk | SURVIVORS | Esophageal Neoplasms - etiology | Breast Neoplasms - surgery | United States - epidemiology | Soft Tissue Neoplasms - etiology | Follow-Up Studies | Humans | Middle Aged | Breast Neoplasms - etiology | Mastectomy - methods | National Cancer Institute (U.S.) | Bone Neoplasms - epidemiology | Antineoplastic Agents - therapeutic use | Radiotherapy - adverse effects | Esophageal Neoplasms - epidemiology | Lung Neoplasms - etiology | Registries - statistics & numerical data | Antineoplastic Agents, Hormonal - therapeutic use | Adult | Female | Mastectomy - statistics & numerical data | Soft Tissue Neoplasms - epidemiology | Breast Neoplasms - epidemiology | Pleural Neoplasms - epidemiology | Survivors | Combined Modality Therapy | Radiotherapy - statistics & numerical data | Breast Neoplasms - drug therapy | Bone Neoplasms - etiology | Pleural Neoplasms - etiology | Neoplasms, Second Primary - epidemiology | Neoplasms, Second Primary - etiology | Breast Neoplasms - radiotherapy | Lung Neoplasms - epidemiology | Aged | Neoplasms, Radiation-Induced - epidemiology | Epidemiology
Journal Article
Cochrane library, ISSN 1465-1858, 2018, Volume 2018, Issue 7, pp. 116 - 117
Background Cancer is a common disease and radiotherapy is one well‐established treatment for some solid tumours... 
'ORPHAN' TOPICS CURRENTLY BEING ADDRESSED | Uterine Cervical Neoplasms | Radiation Tolerance | Neoplasm Recurrence, Local | Techniques to modulate the effects of chemotherapy and/or radiotherapy | Bronchial Neoplasms | Combined Modality Therapy | Urinary Bladder Neoplasms | Head and Neck Neoplasms | Neoplasms | Randomized Controlled Trials as Topic | Rectal Neoplasms | Esophageal Neoplasms | Time Factors | Complementary & alternative medicine | Techniques to modulate the effects of chemotherapy & radiotherapy | Medicine General & Introductory Medical Sciences | Hyperbaric Oxygenation | General cancer treatments | Cancer | Medicine | Evidence | Reprinted from | Abstract | CLINICAL-TRIAL | Humans | Male | Combined Modality Therapy [methods] | NECK-CANCER | RANDOMIZED TRIAL | Bronchial Neoplasms [mortality; radiotherapy] | UTERINE CERVIX | MEDICINE, GENERAL & INTERNAL | Uterine Cervical Neoplasms [mortality; radiotherapy] | Hyperbaric Oxygenation [adverse effects; methods] | Female | Esophageal Neoplasms [mortality; radiotherapy] | Head and Neck Neoplasms [mortality; radiotherapy] | RESEARCH-COUNCIL TRIAL | THERAPY ONCOLOGY GROUP | Rectal Neoplasms [mortality; radiotherapy] | RADIATION-THERAPY | Neoplasm Recurrence, Local [epidemiology] | INTERIM-REPORT | FINAL REPORT | Urinary Bladder Neoplasms [mortality; radiotherapy] | CARCINOMA | Neoplasms [mortality; radiotherapy] | Urinary Bladder Neoplasms - mortality | Bronchial Neoplasms - mortality | Uterine Cervical Neoplasms - radiotherapy | Neoplasms - mortality | Esophageal Neoplasms - radiotherapy | Hyperbaric Oxygenation - adverse effects | Rectal Neoplasms - mortality | Rectal Neoplasms - radiotherapy | Head and Neck Neoplasms - radiotherapy | Bronchial Neoplasms - radiotherapy | Urinary Bladder Neoplasms - radiotherapy | Hyperbaric Oxygenation - methods | Esophageal Neoplasms - mortality | Neoplasms - radiotherapy | Combined Modality Therapy - methods | Neoplasm Recurrence, Local - epidemiology | Head and Neck Neoplasms - mortality | Uterine Cervical Neoplasms - mortality | Index Medicus
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 0027-8874, 01/2018, Volume 110, Issue 1, pp. 109 - 120
Background: Cancer-associated fibroblasts (CAFs) are tumor-promoting and correlate with poor survival in many cancers, which has led to their emergence as... 
CELL LUNG-CANCER | PHASE-II TRIAL | OXIDATIVE STRESS | ONCOLOGY | NAB-PACLITAXEL | ACTIVATION PROTEIN | DEPENDENT INVASION | PANCREATIC-CANCER | MONOCLONAL-ANTIBODY | DIFFERENTIATION | STROMAL CELLS | Lung Neoplasms - drug therapy | Up-Regulation | Pyrazoles - therapeutic use | Reactive Oxygen Species - metabolism | Cell Count | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Head and Neck Neoplasms - chemistry | RNA Interference | Cancer-Associated Fibroblasts - chemistry | Aged, 80 and over | NADPH Oxidases - genetics | Adenocarcinoma - chemistry | Esophageal Neoplasms - chemistry | Lung Neoplasms - chemistry | NADPH Oxidases - antagonists & inhibitors | Head and Neck Neoplasms - drug therapy | Carcinoma, Squamous Cell - chemistry | Survival Rate | Adenocarcinoma - drug therapy | Disease Progression | Phenotype | Carcinoma, Squamous Cell - drug therapy | Head and Neck Neoplasms - genetics | Mice | Neoplasm Transplantation | Carcinoma, Non-Small-Cell Lung - chemistry | Carcinoma, Squamous Cell - genetics | Colorectal Neoplasms - chemistry | Cell Transdifferentiation - genetics | Myofibroblasts - chemistry | Actins - analysis | Cell Transdifferentiation - drug effects | Adult | Female | Adenocarcinoma - genetics | Cancer-Associated Fibroblasts - physiology | Pyridines - therapeutic use | Lung Neoplasms - genetics | Myofibroblasts - pathology | Carcinoma, Non-Small-Cell Lung - genetics | NADPH Oxidases - analysis | Mouth Neoplasms - chemistry | NADPH Oxidase 4 | Cancer-Associated Fibroblasts - pathology | Animals | Esophageal Neoplasms - genetics | Mouth Neoplasms - pathology | Oropharyngeal Neoplasms - chemistry | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Colorectal Neoplasms - pathology | Esophageal Neoplasms - drug therapy
Journal Article
CA: a cancer journal for clinicians, ISSN 0007-9235, 2015, Volume 65, Issue 2, pp. 87 - 108
Journal Article